PWMAI
AMRX icon

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Amneal Pharmaceuticals AMRX Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,758
Closed -$71.2K – 322
2022
Q4 		$71.2K Buy
+35,758
New +$80.2K 0.06% 139

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s AMRX Position: Q1 2023 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of Amneal Pharmaceuticals (AMRX) in Q1 2023, closing a stake of 35,758 shares — an estimated $71.2K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in AMRX in Q4 2022 and held it in 1 quarter. The position peaked at $71.2K in Q4 2022. 144 funds tracked by Wall St. Rank hold AMRX as of Q1 2023.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining Amneal Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 35,758 Amneal Pharmaceuticals shares in Q1 2023, an estimated $71.2K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Amneal Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Amneal Pharmaceuticals position peaked at $71.2K in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2023.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q1 2023, filed 7 Aug 2026.